Understanding the Role of Law in Reducing Firearm Injury through Clinical Interventions

Blake N Shultz1, Carolyn T Lye1, Gail D'Onofrio1

  • 1Blake N. Shultz is a sixth-year medical student at Yale School of Medicine and a third-year law student at Yale Law School, in New Haven, CT. He is also a fellow at the Solomon Center for Health Law and Policy at Yale Law School. He received his B.A. from Cornell University (2015) in Ithaca, NY. Carolyn T. Lye is a fifth-year medical student at Yale School of Medicine and a second-year law student at Yale Law School in New Haven, CT. She received her BA from University of Pennsylvania (2016) in Philadelphia, PA. Gail D'Onofrio, M.D., M.S., is Professor and Chair of Emergency Medicine at Yale School of Medicine and Professor in the School of Public Health. She is also the Chief of Emergency Services for Yale New Haven Hospital. Abbe R. Gluck, J.D., is Professor of Law and the Founding Faculty Director of the Solomon Center for Health Law and Policy at Yale Law School and Professor of Medicine at Yale School of Medicine. Jonathan Miller, J.D., is the former Chief of the Public Protection and Advocacy Bureau at the Office of the Massachusetts Attorney General. Katherine Kraschel, J.D., is the Executive Director of the Solomon Center for Health Law and Policy as well as a Lecturer in Law, Clinical Lecturer in Law, and Research Scholar in Law at Yale Law School. She received her JD from Harvard Law School, and her BA from Mount Holyoke College. Megan L. Ranney, M.D., M.P.H., is an Associate Professor Emergency Medicine at Alpert Medical School and Directof of the Center for Digital Health at Brown University. She is also Chief Research Officer for the American Foundation for Firearm Injury Reduction in Medicine (AFFIRM Research).

Summary

Physicians face legal barriers in firearm injury prevention. Understanding these firearm laws and regulations is crucial for effective patient counseling and injury mitigation strategies.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
136
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
940
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
362
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
118